BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32028069)

  • 1. Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome.
    Zhou R; Li S; Liu J; Wu H; Yao G; Sun Y; Chen ZJ; Li W; Du Y
    EBioMedicine; 2020 Feb; 52():102635. PubMed ID: 32028069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin-producing hepatocellular A7 triggering ovulation indicates a potential beneficial role for polycystic ovary syndrome.
    Li S; Zhai J; Liu J; Di F; Sun Y; Li W; Chen ZJ; Du Y
    EBioMedicine; 2018 Oct; 36():539-552. PubMed ID: 30292674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
    Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
    Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction.
    Liu X; Sun C; Zou K; Li C; Chen X; Gu H; Zhou Z; Yang Z; Tu Y; Qin N; Zhao Y; Wu Y; Meng Y; Ding G; Liu X; Sheng J; Yu C; Huang H
    EBioMedicine; 2020 Nov; 61():103058. PubMed ID: 33096483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS.
    Li X; Lin Y; Cheng X; Yao G; Yao J; Hu S; Zhu Q; Wang Y; Ding Y; Lu Y; Qi J; Zhao H; Bian X; Du Y; Sun K; Vankelecom H; Sun Y
    Hum Reprod Open; 2024; 2024(2):hoae013. PubMed ID: 38550897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome.
    Zhang C; Ma J; Wang W; Sun Y; Sun K
    Hum Reprod; 2018 Nov; 33(11):2096-2106. PubMed ID: 30272163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells.
    Kurakula K; Vos M; Otermin Rubio I; Marinković G; Buettner R; Heukamp LC; Stap J; de Waard V; van Tiel CM; de Vries CJ
    PLoS One; 2014; 9(4):e94931. PubMed ID: 24736599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
    Matulis CK; Mayo KE
    Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four and a half LIM domain 2 alters the impact of aryl hydrocarbon receptor on androgen receptor transcriptional activity.
    Kollara A; Brown TJ
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):51-8. PubMed ID: 19815066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
    Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
    J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
    Jing YX; Li HX; Yue F; Li YM; Yu X; He JJ; Zhang XH
    Gynecol Endocrinol; 2023 Oct; 39(1):2276167. PubMed ID: 37931646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, location and biological effects of four and a half LIM domain protein 2 (FHL2) on granulosa cells in ovine.
    Zhang L; Li R; Chen L; Xing Z; Song Y; Nie X; Wang L; Han H; Liu A; Ma X; Ma RZ; Tian S
    Reprod Domest Anim; 2020 Jun; 55(6):737-746. PubMed ID: 32181932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK.
    Jin J; Ma Y; Tong X; Yang W; Dai Y; Pan Y; Ren P; Liu L; Fan HY; Zhang Y; Zhang S
    Hum Reprod; 2020 May; 35(5):1145-1158. PubMed ID: 32372097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate genes for polycystic ovary syndrome are regulated by TGFβ in the bovine foetal ovary.
    Azumah R; Liu M; Hummitzsch K; Bastian NA; Hartanti MD; Irving-Rodgers HF; Anderson RA; Rodgers RJ
    Hum Reprod; 2022 May; 37(6):1244-1254. PubMed ID: 35413103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility.
    Fan HY; Liu Z; Shimada M; Sterneck E; Johnson PF; Hedrick SM; Richards JS
    Science; 2009 May; 324(5929):938-41. PubMed ID: 19443782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRIM19 deficiency aggravates metabolic disorder and ovarian dysfunction in PCOS.
    Yang L; Yang Y; Han X; Huang C; Wang Y; Jiang D; Chao L
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167063. PubMed ID: 38360073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
    Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
    J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.